Evidence map›Paper›PMID 42281400›Full record

ArticleBriefings in bioinformatics2026

gSV: a general structural variant detector using the third-generation sequencing data.

Jingyu Hao, Jiandong Shi, Sheng Lian, Zhen Zhang, Yongyi Luo, Taobo Hu, Toyotaka Ishibashi, Depeng Wang, Shu Wang, Xiaodan Fan and 1 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jingyu HaoDepartment of Electronic and Computer Engineering, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, 999077, China.ORCID 0000-0002-3301-4439
Jiandong ShiDepartment of Statistics and Data Science, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, 999077, China.ORCID 0000-0002-5178-8470
Sheng LianDepartment of Electronic and Computer Engineering, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, 999077, China.ORCID 0000-0002-0773-8329
Zhen ZhangDepartment of Electronic and Computer Engineering, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, 999077, China.ORCID 0000-0001-7905-7269
Yongyi LuoDepartment of Statistics and Data Science, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, 999077, China.ORCID 0000-0002-0447-329X
Taobo HuDepartment of Breast Surgery, Peking University People's Hospital, No. 11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.ORCID 0000-0001-5124-7167
Toyotaka IshibashiDivision of Life Science, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, 999077, China.ORCID 0000-0001-8015-2319
Depeng WangGrandOmics Inc, Zhongguancun Life Science Park, Changping District, Beijing, 102206, China.ORCID 0000-0001-9014-710X
Shu WangDepartment of Breast Surgery, Peking University People's Hospital, No. 11, Xizhimen South Street, Xicheng District, Beijing, 100044, China.ORCID 0000-0002-8651-4795
Xiaodan FanDepartment of Statistics and Data Science, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, 999077, China.ORCID 0000-0002-2744-9030
Weichuan YuDepartment of Electronic and Computer Engineering, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, 999077, China.ORCID 0000-0002-5510-6916

Funding

HKSAR Government 7015-23GHKSAR Government ITS/043/23HKSAR Government MHP/033/20HKSAR Government R4012-18HKSAR Government T12-101/23-NHKUST 3030_009HKUST BGF.001.2023HKUST CSSET24SC01HKUST OKT26EG06HKUST Z1056National Key Research and Development Program of China 2021YFE0203200
6 · The paper itself

Abstract

Structural variants (SVs) are major contributors to genome diversity and disease susceptibility, particularly in cancer. Although third-generation sequencing technologies have substantially improved SV detection sensitivity, accurate detection of complex SVs remains challenging due to fragmented and heterogeneous alignment signals, as well as the dependence of many existing methods on predefined variant models. In this paper, we propose gSV, a general SV detector that integrates alignment-based and assembly-based approaches with the maximum exact match strategy, with particular emphasis on resolving SVs with complex or atypical alignment signatures. Without predefined assumptions about SV types, gSV captures diverse variant signals, enabling the detection of SVs that are usually missed by conventional tools. Benchmarking using both simulated datasets and real long-read sequencing data demonstrates that gSV achieves improved sensitivity and overall detection performance compared with current state-of-the-art SV callers, particularly for simple and complex SV events with complex alignment patterns. Unique SV discoveries in four breast cancer cell lines, particularly in cancer-associated genes, demonstrate the potential biological relevance of gSV-enabled discoveries. Furthermore, analysis of a breast cancer cohort from the Chinese population highlights the utility of gSV for population-scale genomic studies. Collectively, gSV provides a unified framework for comprehensive SV discovery in both research and clinical genomics settings.

Indexed as

Breast NeoplasmsGenomic Structural VariationHigh-Throughput Nucleotide SequencingSoftwareAlgorithmsCell Line, TumorFemaleGenomicsHumansSequence Analysis, DNAcomplex structural variantstructural variant detectionthird-generation sequencing

Identifiers

PMID42281400
PMCPMC13256234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.